1. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27 3:193-210; doi: 10.1111/j.1468-2982.2007.01288.x.
2. Mann JD, Faurot KR, MacIntosh B, Palsson OS, Suchindran CM, Gaylord SA, et al. A sixteen-week three-armed, randomized, controlled trial investigating clinical and biochemical effects of targeted alterations in dietary linoleic acid and n-3 EPA+DHA in adults with episodic migraine: Study protocol. Prostaglandins Leukot Essent Fatty Acids. 2018;128:41-52; doi: 10.1016/j.plefa.2017.11.002.
3. Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech. 2001;53 3:167-78; doi: 10.1002/jemt.1081.
4. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64 10 suppl 2:S9-S15; doi: 10.1212/WNL.64.10_suppl_2.S9.
5. Tietjen GE, Khubchandani J, Herial N, Palm-Meinders IH, Koppen H, Terwindt GM, et al. Migraine and vascular disease biomarkers: A population-based case-control study. Cephalalgia. 2017:333102417698936; doi: 10.1177/0333102417698936.
6. Mahajan R, Mahajan R, Juneja A, Anand K. Inflammatory biomarkers in migraine- A prospective observational study. International Journal of Scientific Research. 2020.
7. Sarıcam G. Relationship between migraine headache and hematological parameters. Acta Neurol Belg. 2020.
8. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001;21 5:549-57; doi: 10.1046/j.1468-2982.2001.00196.x.
9. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007;11 4:245-8.
10. Du X, Tang Y, Xu H, Lit L, Walker W, Ashwood P, et al. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: Comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics. 2006;87 6:693-703; doi: http://dx.doi.org/10.1016/j.ygeno.2006.02.003.
11. Nagata E, Hattori H, Kato M, Ogasawara S, Suzuki S, Shibata M, et al. Identification of biomarkers associated with migraine with aura. Neurosci Res. 2009;64 1:104-10; doi: 10.1016/j.neures.2009.02.001.
12. Gerring ZF, Powell JE, Montgomery GW, Nyholt DR. Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways. Cephalalgia. 2017:333102416686769; doi: 10.1177/0333102416686769.
13. Arumugam M, Parthasarathy V. Reduction of CD4+CD25+ regulatory T-cells in migraine: Is migraine an autoimmune disorder? J Neuroimmunol. 2016;290:54-9; doi: http://dx.doi.org/10.1016/j.jneuroim.2015.11.015.
14. Sampath P, Moideen K, Ranganathan UD, Bethunaickan R. Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection. Frontiers in Immunology. 2018;9 1726; doi: 10.3389/fimmu.2018.01726.
15. Waschbisch A, Schroder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196 4:1558-67; doi: 10.4049/jimmunol.1501960.
16. Wong KL, Yeap WH, Tai JJY, Ong SM, Dang TM, Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012;53 1:41-57; doi: 10.1007/s12026-012-8297-3.
17. Auffray C, Sieweke MH, Geissmann F. Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells. Annu Rev Immunol. 2009;27 1:669-92; doi: doi:10.1146/annurev.immunol.021908.132557.
18. Saha P, Geissmann F. Toward a functional characterization of blood monocytes. Immunol Cell Biol. 2011;89 1:2-4.
19. Veenstra M, León-Rivera R, Li M, Gama L, Clements JE, Berman JW. Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders. mBio. 2017;8 5:e01280-17; doi: 10.1128/mBio.01280-17.
20. van Sleen Y, Wang Q, van der Geest KSM, Westra J, Abdulahad WH, Heeringa P, et al. Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis. Scientific reports. 2017;7 1:6553-; doi: 10.1038/s41598-017-06826-4.
21. Nicholson JK, Rao PE, Calvelli T, Stetler-Stevenson M, Browning SW, Yeung L, et al. Artifactual staining of monoclonal antibodies in two-color combinations is due to an immunoglobulin in the serum and plasma. Cytometry. 1994;18 3:140-6; doi: 10.1002/cyto.990180305.
22. Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous. Scientific Reports. 2015;5 1:13886; doi: 10.1038/srep13886.
23. Choromańska B, Myśliwiec P, Choromańska K, Dadan J, Chabowski A. The role of CD36 receptor in the pathogenesis of atherosclerosis. Adv Clin Exp Med. 2017;26 4:717-22; doi: 10.17219/acem/62325.
24. Laugerette F, Passilly-Degrace P, Patris B, Niot I, Febbraio M, Montmayeur J-P, et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. The Journal of Clinical Investigation. 2005;115 11:3177-84; doi: 10.1172/JCI25299.
25. Xie S, Lee YF, Kim E, Chen LM, Ni J, Fang LY, et al. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proc Natl Acad Sci U S A. 2009;106 32:13353-8; doi: 10.1073/pnas.0905724106.
26. Zheng JS, Chen J, Wang L, Yang H, Fang L, Yu Y, et al. Replication of a Gene-Diet Interaction at CD36, NOS3 and PPARG in Response to Omega-3 Fatty Acid Supplements on Blood Lipids: A Double-Blind Randomized Controlled Trial. EBioMedicine. 2018;31:150-6; doi: 10.1016/j.ebiom.2018.04.012.
27. Coburn CT, Knapp FF, Jr., Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem. 2000;275 42:32523-9; doi: 10.1074/jbc.M003826200.
28. Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013;154 11:2441-51; doi: 10.1016/j.pain.2013.07.028.
29. Ramsden CE, Zamora D, Faurot KR, MacIntosh B, Horowitz M, Keyes GS, et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ. 2021;374:n1448; doi: 10.1136/bmj.n1448.
30. Yuan F, Wang H, Tian Y, Li Q, He L, Li N, et al. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study. Lipids Health Dis. 2016;15:20; doi: 10.1186/s12944-016-0190-y.
31. Alexander Aguilera A, Hernández Díaz G, Lara Barcelata M, Angulo Guerrero O, Oliart Ros RM. Induction of Cd36 expression elicited by fish oil PUFA in spontaneously hypertensive rats. The Journal of Nutritional Biochemistry. 2006;17 11:760-5; doi: https://doi.org/10.1016/j.jnutbio.2005.12.007.
32. Empl M, Sostak P, Breckner M, Riedel M, Muller N, Gruber R, et al. T-cell subsets and expression of integrins in peripheral blood of patients with migraine. Cephalalgia. 1999;19 8:713-7; discussion 697; doi: 10.1046/j.1468-2982.1999.019008713.x.
33. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, et al. Proinflammatory Cytokines, Adhesion Molecules, and Lymphocyte Integrin Expression in the Internal Jugular Blood of Migraine Patients Without Aura Assessed Ictally. Headache: The Journal of Head and Face Pain. 2006;46 2:200-7; doi: 10.1111/j.1526-4610.2006.00337.x.
34. Kothur K, Wienholt L, Brilot F, Dale RC. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. Cytokine. 2016;77:227-37; doi: https://doi.org/10.1016/j.cyto.2015.10.001.
35. Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70-82; doi: https://doi.org/10.1016/j.neuropharm.2014.10.027.
36. Ramachandran R. Neurogenic inflammation and its role in migraine. Seminars in Immunopathology. 2018;40 3:301-14; doi: 10.1007/s00281-018-0676-y.
37. Thomas G, Tacke R, Hedrick CC, Hanna RN. Nonclassical patrolling monocyte function in the vasculature. Arterioscler Thromb Vac Biol. 2015;35 6:1306-16; doi: 10.1161/atvbaha.114.304650.
38. Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Frontiers in Immunology. 2014;5:514; doi: 10.3389/fimmu.2014.00514.
39. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports. 2014;6:13; doi: 10.12703/P6-13.
40. Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: A review. Veterinary world. 2018;11 5:627-35; doi: 10.14202/vetworld.2018.627-635.
41. Kapellos TS, Bonaguro L, Gemünd I, Reusch N, Saglam A, Hinkley ER, et al. Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. Frontiers in immunology. 2019;10:2035-; doi: 10.3389/fimmu.2019.02035.
42. Min D, Brooks B, Wong J, Salomon R, Bao W, Harrisberg B, et al. Alterations in Monocyte CD16 in Association with Diabetes Complications. Mediators Inflamm. 2012;2012:649083; doi: 10.1155/2012/649083.
43. Narasimhan PB, Marcovecchio P, Hamers AAJ, Hedrick CC. Nonclassical Monocytes in Health and Disease. Annu Rev Immunol. 2019;37 1:439-56; doi: 10.1146/annurev-immunol-042617-053119.
44. Barrera García A, Gómez-Puerta JA, Arias LF, Burbano C, Restrepo M, Vanegas AL, et al. Infiltrating CD16+ Are Associated with a Reduction in Peripheral CD14+CD16++ Monocytes and Severe Forms of Lupus Nephritis. Autoimmune Diseases. 2016;2016:9324315; doi: 10.1155/2016/9324315.
45. La Mantia L, Prone V. Headache in multiple sclerosis and autoimmune disorders. Neurol Sci. 2015;36 Suppl 1:75-8; doi: 10.1007/s10072-015-2146-9.
46. Veenstra M, Williams DW, Calderon TM, Anastos K, Morgello S, Berman JW. Frontline Science: CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol. 2017;102 5:1173-85; doi: 10.1189/jlb.3HI0517-167R.
47. Chatterjee M, von Ungern-Sternberg SNI, Seizer P, Schlegel F, Büttcher M, Sindhu NA, et al. Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4–CXCR7. Cell Death & Disease. 2015;6 11:e1989-e; doi: 10.1038/cddis.2015.233.
48. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97 2:553-622; doi: 10.1152/physrev.00034.2015.
49. DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V. The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci. 2014;8:302; doi: 10.3389/fncel.2014.00302.
50. Febbraio M, Silverstein RL. CD36: Implications in Cardiovascular Disease. The international journal of biochemistry & cell biology. 2007;39 11:2012-30; doi: 10.1016/j.biocel.2007.03.012.
51. Kennedy DJ, Kuchibhotla S, Westfall KM, Silverstein RL, Morton RE, Febbraio M. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res. 2011;89 3:604-13.
52. Sharif O, Matt U, Saluzzo S, Lakovits K, Haslinger I, Furtner T, et al. The scavenger receptor CD36 downmodulates the early inflammatory response while enhancing bacterial phagocytosis during pneumococcal pneumonia. J Immunol. 2013;190 11:5640-8; doi: 10.4049/jimmunol.1202270.
53. Gormley P, Winsvold BS, Nyholt DR, Kallela M, Chasman DI, Palotie A. Migraine genetics: from genome-wide association studies to translational insights. Genome Med. 2016;8 1:86; doi: 10.1186/s13073-016-0346-4.
54. Khaiboullina SF, Mendelevich EG, Shigapova LH, Shagimardanova E, Gazizova G, Nikitin A, et al. Cerebellar Atrophy and Changes in Cytokines Associated with the CACNA1A R583Q Mutation in a Russian Familial Hemiplegic Migraine Type 1 Family. Front Cell Neurosci. 2017;11:263; doi: 10.3389/fncel.2017.00263.
55. Zhang J-M, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45 2:27-37; doi: 10.1097/AIA.0b013e318034194e.
56. Patti F, Nicoletti A, Pappalardo A, Castiglione A, Lo Fermo S, Messina S, et al. Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosis. Acta Neurol Scand. 2012;125 2:91-5; doi: 10.1111/j.1600-0404.2011.01532.x.
57. Franceschini A, Vilotti S, Ferrari MD, van den Maagdenberg AMJM, Nistri A, Fabbretti E. TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PloS one. 2013;8 1:e52394-e; doi: 10.1371/journal.pone.0052394.
58. Martelletti P, Zicari A, Realacci M, Fiore G, De Filippis S, Stirparo G, et al. Expression of NOS–2, COX–2 and Th1/Th2 cytokines in migraine. The Journal of Headache and Pain. 2001;2 Suppl 1:s51-s6; doi: 10.1007/s101940170010.
59. Munno I, Centonze V, Marinaro M, Bassi A, Lacedra G, Causarano V, et al. Cytokines and Migraine: Increase of IL-5 and IL-4 Plasma Levels. Headache: The Journal of Head and Face Pain. 1998;38 6:465-7; doi: 10.1046/j.1526-4610.1998.3806465.x.
60. Kong BS, Kim Y, Kim GY, Hyun J-W, Kim S-H, Jeong A, et al. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder. Journal of Neuroinflammation. 2017;14 1:191; doi: 10.1186/s12974-017-0961-z.
61. Slaney CY, Toker A, La Flamme A, Bäckström BT, Harper JL. Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity. Immunol Cell Biol. 2011;89 1:7-13; doi: 10.1038/icb.2010.110.